Roshanravan H, Dryer SE. ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species. Am J Physiol Renal Physiol 306: F1088-F1097, 2014. First published February 19, 2014 doi:10.1152/ajprenal.00661.2013.-Extracellular ATP may contribute to Ca 2ϩ signaling in podocytes during tubuloglomerular feedback (TGF) and possibly as a result of local tissue damage. TRPC6 channels are Ca 2ϩ -permeable cationic channels that have been implicated in the pathophysiology of podocyte diseases. Here we show using whole cell recordings that ATP evokes robust activation of TRPC6 channels in mouse podocyte cell lines and in rat podocytes attached to glomerular capillaries in ex vivo glomerular explants. The EC50 for ATP is ϳ10 M and is maximal at 100 M, and currents were blocked by the P2 antagonist suramin. In terms of maximal currents that can be evoked, ATP is the strongest activator of podocyte TRPC6 that we have characterized to date. Smaller currents were observed in response to ADP, UTP, and UDP. ATP-evoked currents in podocytes were abolished by TRPC6 knockdown and by pretreatment with 10 M SKF-96365 or 50 M La 3ϩ . ATP effects were also abolished by inhibiting G protein signaling and by the PLC/PLA2 inhibitor D-609. ATP effects on TRPC6 were also suppressed by knockdown of the slit diaphragm scaffolding protein podocin, and also by tempol, a membrane-permeable quencher of reactive oxygen species. Modulation of podocyte TRPC6 channels, especially in foot processes, could provide a mechanism for regulation of glomerular function by extracellular nucleotides, possibly leading to changes in permeation through slit diaphragms. These results raise the possibility that sustained ATP signaling could contribute to foot process effacement, Ca 2ϩ -dependent changes in gene expression, and/or detachment of podocytes. podocyte; glomerular filtration; TRPC6; purinergic; podocin; NADPH oxidase PODOCYTES are highly polarized cells that cover the external surface of the glomerular capillary. Podocyte foot processes attach to the capillary basement membrane and are also connected to each other through specialized junctions known as slit diaphragms (33). The extracellular portions of slit diaphragms are formed from the interacting ectodomains of adhesion molecules such as nephrin and Neph1, which collectively comprise a porous matrix through which water and small solutes pass as a result of hydrodynamic and diffusive driving forces. The permselective properties of slit diaphragms normally prevent significant movement of albumin and comparably sized macromolecules into the urinary space inside Bowman's capsule. While slit diaphragms and foot processes are often depicted as static structures, there is evidence that dynamic processes within foot processes can alter the passage of solutes through slit diaphragms (13, 35) and may in this way contribute to regulation of glomerular filtration rate (GFR). Even more dramatic changes in the shape of podocytes may allow for a stronger attachment to the glomerular capillary in the face of injury or stress, although this typically occurs at the expense of normal glomerular filtration (29).
PODOCYTES are highly polarized cells that cover the external surface of the glomerular capillary. Podocyte foot processes attach to the capillary basement membrane and are also connected to each other through specialized junctions known as slit diaphragms (33) . The extracellular portions of slit diaphragms are formed from the interacting ectodomains of adhesion molecules such as nephrin and Neph1, which collectively comprise a porous matrix through which water and small solutes pass as a result of hydrodynamic and diffusive driving forces. The permselective properties of slit diaphragms normally prevent significant movement of albumin and comparably sized macromolecules into the urinary space inside Bowman's capsule. While slit diaphragms and foot processes are often depicted as static structures, there is evidence that dynamic processes within foot processes can alter the passage of solutes through slit diaphragms (13, 35) and may in this way contribute to regulation of glomerular filtration rate (GFR). Even more dramatic changes in the shape of podocytes may allow for a stronger attachment to the glomerular capillary in the face of injury or stress, although this typically occurs at the expense of normal glomerular filtration (29) .
GFR is regulated by a number of feedback mechanisms that operate over several time scales (14, 15) . A mechanism of particular importance is tubuloglomerular feedback (TGF), a process in which cells of the macula densa detect changes in distal tubule flow rate and luminal Na ϩ content and initiate signals in response that ultimately act on glomerular cells to control GFR (26, 48) . While a vast body of work on TGF has focused on regulation of vascular smooth muscle in the afferent and efferent arterioles (41, 42, 45, 46) , recent studies have provided evidence that TGF generates a Ca 2ϩ wave that propagates from smooth muscle through extra-and intraglomerular mesangial cells, into endothelial cells, and finally, some 20 -40 s later, into podocytes (34) . Importantly, the propagation of this Ca 2ϩ wave was suppressed by extracellular ATP scavengers, and by blockade of P2 purinergic receptors (34) . In recent years it has become clear that connexin and pannexin hemichannels can allow for regulated ATP release from a wide variety of cells (5, 31) . It is notable that glomerular endothelial cells (GEnCs) express connexin 40, which mediates release of ATP and propagation of Ca 2ϩ waves, in part by extracellular diffusion of ATP (50) . Since only a short diffusion distance would be required for ATP secreted from endothelial cells to act on podocytes, this provides a potential mechanism for propagation of the final phase of the glomerular Ca 2ϩ wave observed in TGF. Something like this would appear to be necessary, since podocytes and GEnCs lie on opposite sides of the GBM and therefore cannot be connected by gap junctions.
The purpose of the present study is to examine the actions of ATP on canonical transient receptor potential-6 (TRPC6) channels in podocytes. TRPC6 channels are Ca 2ϩ -permeable cationic channels that play a role in G protein-mediated signaling in a wide variety of cell types (6) . Podocyte TRPC6 channels in podocytes are expressed in foot processes in a complex with other slit diaphragm proteins, including podocin and nephrin (1, 7, 17, 40) . However, TRPC6 is also detected in the major processes and in the podocyte cell body (7) , where it probably exists in different macromolecular complexes (1, 4, 7, 22) . TRPC6 is of particular interest because mutations in these channels result in familial nephrotic syndromes (11, 40, 55) . Moreover, podocyte TRPC6 channels are upregulated in several acquired glomerular diseases (32) , and podocyte-specific overexpression of wild-type or mutant TRPC6 channels in mice results in proteinuria and glomerulosclerosis (28) . There-fore there is considerable interest in understanding the physiological mediators and transduction cascades that can cause these channels to become active. ATP is an attractive candidate because of its role in TGF, and because earlier studies have shown that it could evoke an increase in intracellular Ca 2ϩ in podocytes (10, 18) .
We now report that ATP evokes a concentration-dependent increase in current through TRPC6 channels in immortalized mouse podocyte cell lines, and in primary rat podocytes that are still attached to the GBM in explanted decapsulated glomeruli. The effects of ATP are blocked by the pan-P2 antagonist suramin as well as by inhibition of G protein signaling, and mimicked by P2Y agonists such as ADP and UTP. These effects of ATP are also blocked by TRPC6 knockdown using siRNA and by TRPC6 blocking agents. We also report that podocin is required for robust responses to ATP in podocytes, and we present evidence suggesting that reactive oxygen species play a role in the overall signal transduction cascade leading from P2Y receptors to TRPC6.
MATERIALS AND METHODS
Podocyte cell culture, glomerular isolation, immunoblot analysis, and siRNA procedures. An immortalized mouse podocyte cell line (MPC-5) was obtained from Dr. Peter Mundel of Harvard Medical School and maintained as described previously (23) . Podocyte differentiation and expression of podocyte markers were induced by removal of ␥-interferon and temperature switch to 37°C for 14 days. For glomerular isolation, male Sprague-Dawley rats (150 -200 g from Charles River Laboratories) were anesthetized with isoflurane and euthanized according to NIH guidelines as approved by the University of Houston Institutional Animal Care and Use Committee. Glomeruli were immediately isolated using a sieving procedure described previously (1, 2, 44) . Isolated glomeruli were plated for 24 h at 37°C in RPMI-1640 medium supplemented with 10% fetal bovine serum and 100 U/ml penicillin-streptomycin on collagen-coated glass coverslips. By that time they adhered sufficiently tightly to the substrate to allow analysis by whole cell recordings. In some experiments, panels of proprietary siRNAs directed against TRPC6 or podocin, and nontargeted siRNAs for use in control experiments, were obtained from Santa Cruz Biotechnology and transfected into isolated cultured mouse podocytes or isolated rat glomeruli immediately after isolation using Oligofectamine (Invitrogen) in serum-reduced medium according to the manufacturer's directions, as described previously (1, 2, 20 -24) . Analyses of ATP effects by whole cell recording were carried out 24 h after transfection with siRNAs. Immunoblot analyses were carried out as described in previous studies (1) using rabbit anti-TRPC6 from Alomone Laboratories (Jerusalem, Israel) and rabbit anti-podocin from Acris Antibodies (San Diego, CA).
Electrophysiology. Methods for conventional whole cell recordings from podocytes were carried out by standard methods that have been described in detail previously (1, 2, 20 -22) . Recordings were made with an Axopatch 1D amplifier (Molecular Devices) and analyzed using pClamp v 10 software (Molecular Devices). The bath solution contained 150 mM NaCl, 5.4 mM CsCl, 0.8 mM MgCl 2, 5.4 mM CaCl2, and 10 mM HEPES, pH 7.4. Pipette solutions in all experiments contained 10 mM NaCl, 125 mM CsCl, 6.2 mM MgCl2, 10 mM HEPES, and 10 mm EGTA, pH 7.2. The use of Cs ϩ in bath and pipette solutions prevents contamination by current flowing through K ϩ channels that are also expressed in these cells (23) . The relatively high Ca 2ϩ concentration in the bath solution markedly increases stability of whole cell recordings. We also note that replacing NaCl in bath solution with Na-gluconate does not affect the current-voltage characteristics or reversal potential of ATP-evoked currents in these cells, indicating that Cl Ϫ conductance is not contributing to the observed currents (data not shown). In some experiments, the pipette solution also contained guanosine 5=-O-(2-thiodiphosphate) (GDP-␤S), a GDP analog resistant to hydrolysis and phosphorylation that competitively inhibits G protein activation by GTP (8) . ATP in the absence or presence of other agents was applied by gravity feed through the recording chamber. Tricyclodecan-9-yl-xanthogenate (D-609) and tempol were applied to glomeruli 30 min prior to electrophysiological analyses. To monitor TRPC6, currents were periodically evoked by 2.5-s ramp voltage commands (Ϫ80 to ϩ80 mV) from a holding potential of Ϫ40 mV. Whole cell currents were quantified at ϩ80 mV. It is possible to compensate up to 80% of series resistance without introducing oscillations into the current output of the amplifier. Throughout, data are presented as means Ϯ SE, and quantitative comparisons were analyzed using ANOVA followed by Tukey's post hoc test with P Ͻ 0.05 considered significant.
Drugs and reagents. The pan-TRP channel inhibitor 1-[2-(4-methoxyphenyl)]-2-[3-(4-meth-oxyphenyl)propoxy]ethyl-1H-imidazole
hydrochloride (SKF-96365) was obtained from Sigma. ATP, UTP, UDP, ADP, GDP-␤S, tempol, suramin, and D-609 were also obtained from Sigma. The P2Y 2-selective agonist 4-thiouridine-5=-O-(␤,␥-difluoromethylene) triphosphate used in one set of experiments was obtained from Tocris (catalog no. 4333).
RESULTS
Our initial experiments were carried out on the differentiated cells of an immortalized mouse podocyte cell line (MPC-5 cells) that we have used in several previous studies on TRPC6 (1, 2, 20, 21) . Cationic currents were evaluated during application of slow duration (2.5 s) ramp voltage commands (Ϫ80 mV to ϩ80 mV). Application of ATP by gravity-fed bath superfusion evoked large cationic currents that showed substantial outward rectification under our recording conditions (Fig. 1A) and which reversed rapidly upon washout (not shown). The effects of ATP were concentration dependent, with half-maximal currents typically occurring at ϳ10 M (Fig. 1B) , and with maximal responses observed at 100 M (Fig. 1B) . Pretreating podocytes with 100 M suramin completely eliminated responses to ATP (Fig. 1, C and D) , suggesting that they are mediated by P 2 receptors.
The P 2 receptor can be subdivided into seven forms of ionotropic P2X receptors, and a family of eight metabotropic receptors, known as P2Y (1, 2, 3, 4, 6, 11, 12, 13, 14) (52) . Transcripts encoding P2Y 1 , P2Y 2 and P2Y 6 have been detected in rodent podocytes (10) . ATP can activate P2Y 1 and P2Y 2 receptors, whereas UTP can activate P2Y 2 and P2Y 4 receptors. Note, however, that the later are not inhibited by suramin. UDP preferentially activates P2Y 6 , whereas ADP preferentially activates P2Y 1 (52) . We observed that cationic currents qualitatively similar but consistently smaller than those evoked by ATP could be activated by 100 M or 200 M of ADP, UTP, or UDP (Fig. 1E ). Responses were also evoked by the synthetic agonist 4-thiouridine-5=-O-(␤,␥-difluoromethylene) triphosphate at concentrations where it is selective for P2Y 2 receptors (9) (data not shown). For all of these nucleotides, response amplitudes were similar when they were evoked at 100 or 200 M, suggesting that they comprise the top of the concentration-response curves. These data suggest that the functional P2Y 1 , P2Y 2 , and P2Y 6 receptors are expressed in mouse podocytes, consistent with earlier investigations on transcript expression (10) . ATP evoked larger responses than any of the other nucleotides, which suggests that its effects are caused by simultaneous activation of multiple subtypes of receptors expressed in these cells, most likely P2Y 1 and P2Y 2 (since it is not able to activate P2Y 6 ).
Irrespective of the relative contributions of the various subtypes of P2Y receptors, responses to ATP were not seen when recording electrodes contained 50 M guanosine 5=-O-(2-thiodiphosphate) (GDP-␤S), a GDP analog resistant to hydrolysis and phosphorylation that competitively inhibits G protein activation by GTP (8) (Fig. 2) . We have previously shown that this pipette solution also blocks responses to angiotensin II (ANG II), although activation of TRPC6 by hypoosmotic stretch persists under those recording conditions (1) . These data indicate that podocyte responses to ATP are mediated by G protein-coupled metabotropic receptors in the P2Y family (10).
The ATP-evoked cationic current appears to flow through endogenously expressed TRPC6 channels. Currents activated by ATP were completely blocked by bath application of 10 M SKF-96365, a nonselective pan-TRP channel inhibitor (Fig.  3A) . Podocytes express TRPC5 and TRPC6 subunits (7, 20, 49) , and those two types of channels are both blocked by SKF-96365 (49). However, they are differentially sensitive to micromolar concentrations of La 3ϩ , as TRPC6 can be completely inhibited by micromolar La 3ϩ , whereas TRPC5 is actually activated by La 3ϩ at that concentration (19, 49) . We observed that 50 M La 3ϩ rapidly and completely blocked currents evoked by 200 M ATP, suggesting that they are mediated by channels containing TRPC6 subunits, and indicating that TRPC5 channels cannot be making a significant contribution to the ATP-evoked currents in these cells (Fig.  3B) . Consistent with this, we observed that transient siRNA knockdown of TRPC6 using procedures described previously (1, 2, 20) abolished podocyte responses to ATP, whereas cells continued to respond to ATP after treatment with a control siRNA (Fig. 4) . The effectiveness of the siRNA was confirmed by immunoblot (Fig. 4D) .
Previous studies have shown that P2Y 1 , P2Y 2 , and P2Y 6 receptors are preferentially coupled to G q (52) and therefore have the potential to activate phospholipases that feed into TRPC6 (12) . The role of phospholipases in TRP channel signaling must be assessed with caution, because several of the most commonly used phospholipase inhibitors, such as U-73102, are direct inhibitors of certain TRP channels, including TRPC6 (Ref. 27 and unpublished observations). However, we have observed that tricyclodecan-9-yl-xanthogenate (D-609) can be used for experiments on TRPC6 channels, since it does not block responses evoked by diacylglycerol analogs. D-609 inhibits phosphatidylcholine-specific forms of phospholipase C (PLC) as well as certain forms of phospholipase A 2 . We observed that pretreatment with 100 M D-609 for 30 min abolished responses to ATP (Fig. 5) , suggesting that signaling from P2Y receptors to TRPC6 channels in podocytes entails activation of phospholipases.
Previous studies have shown that TRPC6 channels of podocytes become active in response to signals that increase generation of reactive oxygen species (2, 20, 21) , including rapidly acting signals such as ANG II (2). We observed that 30 min pretreatment with 10 mM tempol, a membrane-permeable superoxide dismutase mimetic, abolished responses to ATP (Fig. 6) , suggesting a pathway similar to the one we previously described for ANG II (2) . In a more recent study we observed that podocyte TRPC6 channels reside in multiprotein complexes that include the NADPH oxidase NOX2, which can generate ROS locally to facilitate TRPC6 activation in podocytes (22) . The interaction between TRPC6 and NOX2 is indirect, and coimmunoprecipitation of these proteins requires the hairpin-loop inner membrane protein podocin (22) . As with our previous studies on ANG II (2), we observed that podocin knockdown using a panel of siRNAs eliminated ATP activation of TRPC6 channels, whereas responses were readily detected in cells transfected with a control siRNA (Fig. 7) . Immunoblot analysis showed that podocin siRNA produced strong reductions in podocin expression but had no effect on TRPC6 (Fig. 7D) .
It is possible that changes in gene expression and cell physiology occur when podocytes are immortalized and propagated as a cell line. If the response to ATP is physiologically relevant, one would expect to see it in primary podocytes. To this end, we have employed an isolated decapsulated rat glomerulus preparation in which podocytes remain attached to the underlying glomerular basement membrane. This preparation does not require enzymatic digestion, and the podocytes on the external surface of the preparation can be readily seen using Hoffman modulation contrast optics. They are readily accessible to the recording electrode (Fig. 8A) , the bath solution, and any agents that we may include in external culture media or recording solutions. We observed that bath application of ATP evoked robust increases in cationic current in this preparation, and these currents were completely blocked by subsequent exposure to 50 M La 3ϩ (Fig. 8, B and C) . Treating the isolated glomerulus preparation for 24 h with the same TRPC6 siRNAs that we used on the immortalized cell lines resulted in a loss of ATP responses of podocytes located along the outer margin of the preparation, whereas glomeruli treated with control siRNA continued to show robust responses to ATP (Fig. 9) . Immunoblot analysis confirmed reduction in TRPC6 expression by siRNA (Fig. 9D) . Collectively these data indicate that channel complexes containing TRPC6 subunits are required for ATP-evoked cationic currents in primary rat podocytes, as in the immortalized podocyte cell line.
DISCUSSION
In this study we have shown that ATP evokes robust activation of TRPC6 channels in immortalized mouse podocyte cell lines and in primary rat podocytes still attached to the glomerular basement membrane in ex vivo glomeruli. The effects of ATP are mediated by a G protein-coupled pathway from P 2 Y receptors, through a phospholipase, to the TRPC6 channels. At some point, most likely downstream of phospholipases (22) , the transduction cascade generates ROS, which contribute to TRPC6 activation. In addition, the cascade re- quires podocin, which appears to function as a scaffold to allow for spatial colocalization of the various transduction components within cholesterol-rich membrane proteins (1, 17, 22) . In short, the transduction cascade is qualitatively similar to the one used in these cells by ANG II and AT1R receptors, which we have described recently (2) .
Responses to ATP are generally larger than responses to ANG II at concentrations that evoke maximum responses (2) . The robustness of the response to ATP may occur because its signals are simultaneously transduced through multiple forms of P2Y receptors (especially P2Y 1 and P2Y 2 ) (10), whereas ANG II signals to TRPC6 are only transduced by ATR1. Responses to UTP, UDP, and ADP suggest the presence of multiple functional P2Y receptors in these cells, which is largely consistent with a recent study (18) . It should bear noting, however, that this last study did not detect Ca 2ϩ influx in response to UDP. Collectively these observations also suggest that treatments that reduce ATP-evoked Ca 2ϩ overload into foot processes through this pathway could be especially effective therapeutic strategies. In this regard, a previous study has shown that sustained exposure to ATP can cause cell death in podocytes (10) .
In principle, Ca 2ϩ overload in foot processes could be reduced by agents that inhibit TRPC6 channels, or possibly by agents that inhibit ROS generation by NADPH oxidases (54) . The present results raise the possibility that P2Y antagonists might also reduce Ca 2ϩ overload, assuming they could be tolerated. In this regard, P2Y 1 receptors expressed in podocytes have been shown to mediate Ca 2ϩ influx (18) and are also expressed in proximal tubules where they have been proposed to play a role in regulation of bicarbonate transport (3). P2Y 1 knockout mice are viable, but kidney function has not been assessed in these animals. P2Y 2 receptors are expressed in podocytes and in several different nephron segments and play a complex role in regulation of renal electrolyte and water transport (51). P2Y 6 is also expressed in renal vasculature, although it is not responsive to ATP (53) . There is evidence suggesting that locally released ATP may modulate gating and steady-state surface expression of the epithelial sodium channel ENaC in the distal nephron (30, 47, 43, 36, 37) and may also regulate collecting duct aquaporin channels (25) . As a result, there is a net salt-resistant increase in mean arterial pressure in P2Y 2 knockout mice that appears to be associated with changes in multiple homeostatic systems (51) and which is consistent with the idea that global P2Y 2 activation results in a steady diuresis (39) . In addition, P2Y 2 knockout mice actually appeared to be more susceptible to various indexes of kidney damage by 8 wk after subtotal (5/6) nephrectomy, including an increase in albuminuria compared with wild-type mice subjected to the same stress, although there was no increase in glomerulosclerosis in these experiments in the knockout mice (38) . These results would tend to suggest that P2Y 1 or P2Y 2 might be the most promising therapeutic targets for glomerular disease, with the caveat that the P2Y 2 knockout mice used in the studies cited above are complete, global (in every tissue) and constitutive (including during embryonic development) (16) . Therefore it may not be straightforward to compare the physiology of those mice to what might occur with subtotal pharmacological blockade in a system that developed normally.
One question that emerges pertains to the source of ATP that might activate podocyte P 2 Y receptors during normal physiol- ogy. Glomerular endothelial cells are able to secrete ATP through connexin and/or pannexin hemichannels (50), and we favor this as a mechanism for propagation of Ca 2ϩ waves to podocytes during TGF. The question of whether it is adenosine or ATP that carries the initial signals from the macula densa to the afferent arteriole (45, 46) is immaterial as to how the Ca 2ϩ wave is subsequently propagated into the rest of the glomerulus. We know from Lucifer yellow dye-filling experiments that podocytes are not connected to other cells by gap junctions (unpublished data) and therefore orthograde signals must pass into podocytes, and possibly from one podocyte to another, by means of diffusible messengers. ATP is a prime candidate for this, based on previous studies on the effects of suramin and ATP scavengers on propagation of Ca 2ϩ waves through the glomerulus during TGF (34) . Obviously, ATP is also freely filtered, and there would be minimal diffusional barriers for ATP released from glomerular endothelial cells to podocytes. ATP can also be modified by extracellular nucleotidases once control it is secreted and can thereby produce ADP, which is also an effective agonist in podocytes. The sources of UTP or UDP, if any, are not known.
Finally, we should note that podocin knockdown abolished the ability of ATP to evoke cationic currents in podocytes. This is consistent with previous studies showing that podocin potentiates chemical activation of TRPC6 by diacylglycerol analogs (1, 17) . We have recently reported that podocin is required for colocalization of TRPC6 channels and NOX2 in podocytes (22) , which can allow for a locally generated source of ROS to modulate TRPC6 gating as part of a physiological transduction cascade without the need for toxic increases in cytosolic ROS. Thus our observations with podocin knockdown are consistent with the observation that tempol (a ROS quencher) also blocks ATP activation of TRPC6 in podocytes. However, if local ATP concentrations were sustained for a long period of time, for example during inflammation, it might result in oxidative damage to the foot process.
In summary we have demonstrated that ATP evokes activation of TRPC6 channels in podocytes through P2Y receptors, G protein signaling, and generation of reactive oxygen species. ATP-evoked cationic currents are abolished by treatments that inhibit or knockdown TRPC6, and ATP causes the largest activation of TRPC6 of any stimulus that we have examined. Ectonucleotide signaling to podocytes may therefore play a role in normal glomerular filtration or in the pathophysiology of glomerular disease.
